(Mary Ann Liebert, Inc./Genetic Engineering News) Researchers around the globe are working on turning microRNAs, over 5,000 of which already have been identified, into novel drugs for a wide range of applications, reports Genetic Engineering & Biotechnology News. These noncoding single-stranded RNAs act through binding to complementary mRNA sequences, thus preventing their translation into protein or accelerating mRNA breakdown, according to the March 15 issue of GEN.
Read »GEN reports on therapeutic potential of microRNA
http://www.eurekalert.org –